Hepatology

Latest News

 How New Therapies Change Discussions Around Screening, Management of MASH
How New Therapies Change Discussions Around Screening, Management of MASH

March 18th 2024

In the final installment in our 5-part video series, our pair of experts in hepatology touch upon how an approval for MASH would impact conversations around screening for asymptomatic patient populations.

HCPLive Clinical Quiz
Clinical Quiz: Hepatitis C Treatment Duration, Regimen Updates

March 18th 2024

FDA black and white logo | Credit: US Food and Drug Administration
Resmetirom (Rezdiffra) Receives Historic FDA Approval for Noncirrhotic NASH

March 14th 2024

Saeed Mohammed, MD, MS | Credit: Vanderbilt University Medical Center
FDA Approval of Maralixibat for Cholestatic Pruritus in PFIC Signals New Frontier for IBAT Inhibitor

March 13th 2024

Megan Rose Curtis, MD | Credit: Megan Rose Curtis on LinkedIn
Early Treatment of Perinatally Acquired HCV More Cost-Effective Than DAA Deferral

March 13th 2024

Video Interviews
Podcasts
Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD

More News

© 2024 MJH Life Sciences

All rights reserved.